| Serial Number | 87528200 |
| Word Mark | CREATIVE BIOARRAY A DIVISION OF CREATIVE DYNAMICS INC |
| Filing Date | Friday, July 14, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Monday, September 9, 2024 |
| Registration Number | 5411628 |
| Registration Date | Tuesday, February 27, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 12, 2017 |
| Description of Mark | The mark consists of a spherical design composed of three curved triangular shapes in the color blue and one curved triangular shape in the color red. At the center of the spherical design is a blank space in the shape of a square. On the right side of the spherical design are the words "CREATIVE BIOARRAY A DIVISION OF CREATIVE DYNAMICS INC" in black. The color white represents background and is not part of the mark. |
| Indication of Colors claimed | The color(s) blue, red and black is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOARRAY" AND "INC" |
| Goods and Services | Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineering |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Monday, September 9, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, February 1, 2013 |
| First Use In Commerce Date | Friday, February 1, 2013 |
| Party Name | CD BIOSCIENCES INC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Party Name | CD BIOSCIENCES INC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Party Name | CD BIOSCIENCES INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Shirley, NY 11967 |
| Event Date | Event Description |
| Tuesday, July 18, 2017 | NEW APPLICATION ENTERED |
| Thursday, July 20, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 21, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, October 30, 2017 | ASSIGNED TO LIE |
| Wednesday, November 22, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 12, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 12, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, October 13, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, October 17, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 17, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 17, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 17, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, October 19, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 27, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, October 8, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 27, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Monday, September 9, 2024 | CANCELLED SEC. 8 (6-YR) |